relcovaptan has been researched along with Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fathali, N; Khatibi, NH; Lekic, T; Manaenko, A; Martin, R; Shum, KJ; Tang, J; Zhang, JH | 1 |
| Noor, R; Shuaib, A; Xu Wang, C; Yang, T | 1 |
2 other study(ies) available for relcovaptan and Stroke
| Article | Year |
|---|---|
Post-treatment with SR49059 improves outcomes following an intracerebral hemorrhagic stroke in mice.
Topics: Animals; Brain; Brain Edema; Cerebral Hemorrhage; Collagenases; Dose-Response Relationship, Drug; Drug Administration Schedule; Functional Laterality; Hormone Antagonists; Indoles; Male; Mice; Psychomotor Performance; Pyrrolidines; Stroke; Time Factors | 2011 |
Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Behavior, Animal; Brain Edema; Cerebral Infarction; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Hormone Antagonists; Indoles; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Neuroprotective Agents; Pyrrolidines; Rats; Rats, Wistar; Recovery of Function; Stroke; Time Factors; Treatment Outcome | 2002 |